1. Home
  2. LUNG vs INGN Comparison

LUNG vs INGN Comparison

Compare LUNG & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • INGN
  • Stock Information
  • Founded
  • LUNG 1995
  • INGN 2001
  • Country
  • LUNG United States
  • INGN United States
  • Employees
  • LUNG N/A
  • INGN N/A
  • Industry
  • LUNG Industrial Specialties
  • INGN Industrial Specialties
  • Sector
  • LUNG Health Care
  • INGN Health Care
  • Exchange
  • LUNG Nasdaq
  • INGN Nasdaq
  • Market Cap
  • LUNG 251.5M
  • INGN 212.5M
  • IPO Year
  • LUNG 2020
  • INGN 2014
  • Fundamental
  • Price
  • LUNG $6.23
  • INGN $8.47
  • Analyst Decision
  • LUNG Buy
  • INGN Hold
  • Analyst Count
  • LUNG 6
  • INGN 3
  • Target Price
  • LUNG $11.92
  • INGN $7.00
  • AVG Volume (30 Days)
  • LUNG 242.6K
  • INGN 177.3K
  • Earning Date
  • LUNG 02-19-2025
  • INGN 11-07-2024
  • Dividend Yield
  • LUNG N/A
  • INGN N/A
  • EPS Growth
  • LUNG N/A
  • INGN N/A
  • EPS
  • LUNG N/A
  • INGN N/A
  • Revenue
  • LUNG $79,302,000.00
  • INGN $331,520,000.00
  • Revenue This Year
  • LUNG $22.26
  • INGN $6.51
  • Revenue Next Year
  • LUNG $18.72
  • INGN $4.24
  • P/E Ratio
  • LUNG N/A
  • INGN N/A
  • Revenue Growth
  • LUNG 22.34
  • INGN 1.12
  • 52 Week Low
  • LUNG $5.46
  • INGN $5.08
  • 52 Week High
  • LUNG $14.84
  • INGN $13.33
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.37
  • INGN 32.13
  • Support Level
  • LUNG $5.72
  • INGN $8.77
  • Resistance Level
  • LUNG $6.28
  • INGN $9.31
  • Average True Range (ATR)
  • LUNG 0.40
  • INGN 0.45
  • MACD
  • LUNG -0.03
  • INGN -0.15
  • Stochastic Oscillator
  • LUNG 19.85
  • INGN 6.88

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About INGN Inogen Inc

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Share on Social Networks: